Trial · NCT02860546
Results by group28
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 28
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Immune-Related Overall Response Rate (irORR) | TAS-102 + Nivolumab | 0 | percentage of participants | ||
| Number of Participants With Dose Limiting Toxicities (DLTs) | TAS-102 + Nivolumab | 0 | Participants | ||
| Recommended Phase 2 Dose (RP2D) | TAS-102 + Nivolumab | 35 | mg/m^2 | ||
| Number of Participants With Treatment-emergent Adverse Events (TEAEs) and Treatment-emergent Serious Adverse Events (TESAEs) | TAS-102 + Nivolumab | Participants with TEAEs | 18 | participants | |
| Number of Participants With Treatment-emergent Adverse Events (TEAEs) and Treatment-emergent Serious Adverse Events (TESAEs) | TAS-102 + Nivolumab | Participants with TESAEs | 6 | participants | |
| Number of Participants With Grade 3 or Higher Laboratory Tests Abnormalities | TAS-102 + Nivolumab | Grade 4: Neutropenia (neutrophils low) | 3 | participants | |
| Number of Participants With Grade 3 or Higher Laboratory Tests Abnormalities | TAS-102 + Nivolumab | Grade 4: Anemia (hemoglobin low) | 1 | participants | |
| Number of Participants With Grade 3 or Higher Laboratory Tests Abnormalities | TAS-102 + Nivolumab | Grade 4: Leukopenia (leukocytes low) | 0 | participants | |
| Number of Participants With Grade 3 or Higher Laboratory Tests Abnormalities | TAS-102 + Nivolumab | Grade 4: Lymphopenia (lymphocytes low) | 0 | participants | |
| Number of Participants With Grade 3 or Higher Laboratory Tests Abnormalities | TAS-102 + Nivolumab | Grade 4: Thrombocytopenia (platelets low) | 0 | participants | |
| Number of Participants With Grade 3 or Higher Laboratory Tests Abnormalities | TAS-102 + Nivolumab | Grade 4: Bilirubin High | 0 | participants | |
| Number of Participants With Grade 3 or Higher Laboratory Tests Abnormalities | TAS-102 + Nivolumab | Grade 4: Glucose High | 0 | participants | |
| Number of Participants With Grade 3 or Higher Laboratory Tests Abnormalities | TAS-102 + Nivolumab | Grade 4: Sodium Low | 0 | participants | |
| Number of Participants With Grade 3 or Higher Laboratory Tests Abnormalities | TAS-102 + Nivolumab | Grade 3: Neutropenia (neutrophils low) | 3 | participants | |
| Number of Participants With Grade 3 or Higher Laboratory Tests Abnormalities | TAS-102 + Nivolumab | Grade 3: Anemia (hemoglobin low) | 1 | participants | |
| Number of Participants With Grade 3 or Higher Laboratory Tests Abnormalities | TAS-102 + Nivolumab | Grade 3: Leukopenia (leukocytes low) | 6 | participants | |
| Number of Participants With Grade 3 or Higher Laboratory Tests Abnormalities | TAS-102 + Nivolumab | Grade 3: Lymphopenia (lymphocytes low) | 2 | participants | |
| Number of Participants With Grade 3 or Higher Laboratory Tests Abnormalities | TAS-102 + Nivolumab | Grade 3: Thrombocytopenia (platelets low) | 1 | participants | |
| Number of Participants With Grade 3 or Higher Laboratory Tests Abnormalities | TAS-102 + Nivolumab | Grade 3: Bilirubin High | 1 | participants | |
| Number of Participants With Grade 3 or Higher Laboratory Tests Abnormalities | TAS-102 + Nivolumab | Grade 3: Glucose High | 1 | participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02860546/results